Vincristine: a new treatment option for Kasabach-Merritt Syndrome
Journal Title: Internet Journal of Medical Update - Year 2011, Vol 6, Issue 2
Abstract
Kasabach-Merritt syndrome (KMS) is characterized by a rapidly enlarging hemangioma, thrombocytopenia, microangiopathic hemolytic anemia and consumption coagulopathy as a result of platelet and red blood cell trapping and activation of clotting system within the vasculature of hemangioma. This syndrome is shown to be associated with kaposiform hemangioendotheliomas or tufted hemangioma.
Authors and Affiliations
Shalini Avasthi
Keywords
Related Articles
- EP ID EP124380
- DOI -
- Views 76
- Downloads 0
Hypertension prevalence and awareness among a health workforce in Nigeria
Hypertension is now being widely reported in Africa and it is a major factor in the high mortality of adults in sub-Saharan Africa. Unfortunately hypertension is often unnoticed and undiagnosed because it is usually asym...
LONG-STANDING UNREDUCED ANTERIOR DISLOCATION OF THE KNEE - A CASE REPORT
A case of long standing unreduced anterior dislocation of the knee for 2 months has been reported which was treated first with open reduction and external fixation at 70° flexion of knee followed by gradual extension of...
Touch Surgery™ - The Operating Room in your Pocket: a Surgical Simulation app Publisher: Touch Surgery Labs, 230 City Road, London, EC1V 2QY, UK Available for Android and iOS
None
Myoepithelial carcinoma of the male breast
None
NANOSCIENCE IN DIAGNOSTICS: A SHORT REVIEW
Nanoscience is at the leading edge of the rapidly developing field of nanotechnology. Nanosciences and nanotechnology are transforming a wide array of products and services that have the potential to enhance the practice...